Hi-Tech Loses Motion And Now Awaits FDA Decision
A federal judge has rejected Hi-Tech Pharmacal Co. Inc.'s motion for a preliminary injunction that would have prevented other drugmakers from marketing a generic version of the glaucoma drug Cosopt until...To view the full article, register now.
Already a subscriber? Click here to view full article